BIOT
Revolutionizing EV Production: Immortalized hMSCs in Suspension!
**Excerpt:** 🌟 Discover how adapting immortalized hMSCs to suspension culture revolutionizes EV production, boosting scalability and reducing costs! 🚀💡🔬
Conquering Contamination in Gene Therapy Production
🌟 Overcoming sterility challenges in cell and gene therapy is vital! 🧬 Discover solutions for contamination risks and ensure quality! 🔬💡✨
Agilent’s $925M Biovectra Buy: Boosting Growth!
Agilent is acquiring Biovectra for $925M! 💰 This deal enhances CDMO services, especially in mRNA and gene editing. 🚀📦
Capra Biosciences wins $75M to solve pharmaceutical shortages
🔍 Capra Biosciences awarded $7.5M project to scale and manufacture bio-derived small-molecule APIs, addressing ingredient shortages. 🧪🌱🚀
Revolutionizing mRNA Vaccines: Faster Scalable and Effective!
📚 Advancing mRNA Vaccine and Therapy Development discusses progress in mRNA vaccines and therapies, highlighting cell-free cloning for gene synthesis. 🧬💉
Mastering Automation: The Key to Scaling Cell and Gene Therapy
🔬 Learn from other industries! 🏭 Lack of scale-up expertise is a challenge for CGT manufacturers. ⚙️ Master efficient manufacturing methods. 💰 Don't neglect late-stage trials and commercialization. 🤝 Hire experts. 🤖 Automation is crucial.
Revolutionizing Bioprocessing: Achieving Quality by Design
1. 🌱 From Quality by Testing to Quality by Design: How the bioprocessing industry is embracing innovation for better efficiency and consistency. 🚀 2. 🏭 The Ongoing Journey to Quality by Design: Integrating AI, IoT, and digital twin tech for improved bioprocessing outcomes. 🌐
Revolutionary Open-Source Biomanufacturing Simulation Model!
🔬 A new open-source simulation model, KTB1, enables biomanufacturers to optimize continuous biomanufacturing processes with tailored strategies. 🌱
Breaking News: Gene Therapy Partnership Expands!
📢 Univercells Technologies and UPENN are expanding their partnership to evaluate gene therapy manufacturing scalability. 🧪 The goal is accessibility and cost reduction. 💪🏭👨🔬
Unlocking the Potential of Cell and Gene Therapies: The Game-Changing Solution
🧪 The cell and gene therapy market is growing rapidly, but development and manufacturing are complex. 🌍 SmartLabs offers a solution by hosting drug discovery, development, and manufacturing facilities in one location. 💰 This reduces costs and resources needed for non-scientific services, allowing companies to focus on developing robust processes. 💡 SmartLabs' modular facilities are customizable and phase-compliant, making it easier to transition through the drug development journey. 👥 Clients have access to expertise and support, and they retain control over their manufacturing process and IP. 🔬 SmartLabs aims to accelerate scientific breakthroughs and adapt to the evolving life sciences industry.
